You are viewing the "Gilead" Archives
![Gilead Sciences CEO Daniel O'Day speaks at a meeting with President Trump and members of the White House coronavirus task force on March 2.](https://woub.org/wp-content/uploads/2020/05/gilead_oday_ap_20063768810585-fb2def61689c244c27d64d2688038272d27ed0e4-scaled-e1588436641283-900x422.jpg)
Gilead Lobbying Rose As Interest In COVID-19 Treatment Climbed
By: Sydney Lupkin | NPR
Posted on:
On Friday, the Food and Drug Administration authorized emergency use of remdesivir for patients with severe cases of COVID-19. Drugmaker Gilead Sciences’ lobbying hit a new high in the first quarter.